BioCentury | Apr 16, 2021
Finance

April 15 Quick Takes: Co-founded by Springer and Kruse, GPCR play Tectonic raises $80M; plus AltruBio, Rapha, Benchling, BioAge, Amgen

...Timothy Springer, Harvard Medical School professors who are KOLs in membrane protein biochemistry and immunology. Celgene Corp....
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...that landed the company’s 2017 partnership with Celgene Corp....
...company in China. The deal gave the company Celgene’s...
BioCentury | Mar 27, 2021
Regulation

FDA approval solidifies bluebird’s anti-BCMA CAR T as ‘cornerstone’ of BMS’s multiple myeloma portfolio

...Inc. and added to the BMS pipeline through the Celgene...
...gained the program through its acquisition of Celgene...
BioCentury | Mar 27, 2021
Management Tracks

Amgen’s Martin to succeed Lee as Gilead’s EVP of research; plus Medicxi, Bavarian Nordic, Antengene, Arcutis and CASI

...corporate VP to CSO. Lynch previously served as VP, clinical development and medical affairs, Asia-Pacific at Celgene Corp. Arcutis...
BioCentury | Mar 23, 2021
Management Tracks

Brainard to succeed Hallal as AlloVir CEO; plus Illumina, NeoGenomics, Nordic Nanovector, Abeona, Delix and more

...he held various senior executive positions at Kite Pharma Inc., Eisai Co. Ltd. (Tokyo:4523) and Celgene...
BioCentury | Mar 16, 2021
Politics, Policy & Law

FTC’s ‘aggressive’ new approach to pharma merger regulation will include biotech M&A

...November 2019 dissent to the FTC’s decision to allow Bristol Myers Squibb Co. (NYSE:BMY)to acquire Celgene Corp....
...Divergent viewsIn her dissent against the consent agreement that allowed the $74 billion takeout of Celgene...
...he had disingenuously distorted the facts to justify this position. Steve Usdin Alexion Pharmaceuticals Inc. AstraZeneca plc Allergan Inc. AbbVie Inc. Celgene Corp. Bristol...
BioCentury | Mar 6, 2021
Management Tracks

Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more

...before its acquisition by Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). He also served as general manager at Celgene Corp....
BioCentury | Feb 20, 2021
Product Development

BMS turns to mechanistic diversity in early oncology pipeline

...has settled on its 2019 acquisition of Celgene Corp....
...added to the BMS pipeline through the Celgene...
...Keytruda pembrolizumab from Merck & Co. Inc. (NYSE:MRK).The Celgene...
BioCentury | Feb 9, 2021
Product Development

Feb. 8 Quick Takes: FDA approves TG’s lymphoma therapy; plus uniQure, Astellas, BMS, Viiv, Avrobio and Veru

...Corp. (NASDAQ:INCY). BMS gained the JAK2 and FLT3 inhibitor through its $74 billion acquisition of Celgene Corp....
BioCentury | Feb 6, 2021
Politics, Policy & Law

Biotech isn’t tech; M&A isn’t all the same

...Atlas Venture, told BioCentury. As a example of the “recycling component of M&A,” Booth cited Celgene Corp.’s...
...2018, which “sent more cash back to investors than all of the IPOs that year.” Celgene...
Items per page:
1 - 10 of 3394
BioCentury | Apr 16, 2021
Finance

April 15 Quick Takes: Co-founded by Springer and Kruse, GPCR play Tectonic raises $80M; plus AltruBio, Rapha, Benchling, BioAge, Amgen

...Timothy Springer, Harvard Medical School professors who are KOLs in membrane protein biochemistry and immunology. Celgene Corp....
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...that landed the company’s 2017 partnership with Celgene Corp....
...company in China. The deal gave the company Celgene’s...
BioCentury | Mar 27, 2021
Regulation

FDA approval solidifies bluebird’s anti-BCMA CAR T as ‘cornerstone’ of BMS’s multiple myeloma portfolio

...Inc. and added to the BMS pipeline through the Celgene...
...gained the program through its acquisition of Celgene...
BioCentury | Mar 27, 2021
Management Tracks

Amgen’s Martin to succeed Lee as Gilead’s EVP of research; plus Medicxi, Bavarian Nordic, Antengene, Arcutis and CASI

...corporate VP to CSO. Lynch previously served as VP, clinical development and medical affairs, Asia-Pacific at Celgene Corp. Arcutis...
BioCentury | Mar 23, 2021
Management Tracks

Brainard to succeed Hallal as AlloVir CEO; plus Illumina, NeoGenomics, Nordic Nanovector, Abeona, Delix and more

...he held various senior executive positions at Kite Pharma Inc., Eisai Co. Ltd. (Tokyo:4523) and Celgene...
BioCentury | Mar 16, 2021
Politics, Policy & Law

FTC’s ‘aggressive’ new approach to pharma merger regulation will include biotech M&A

...November 2019 dissent to the FTC’s decision to allow Bristol Myers Squibb Co. (NYSE:BMY)to acquire Celgene Corp....
...Divergent viewsIn her dissent against the consent agreement that allowed the $74 billion takeout of Celgene...
...he had disingenuously distorted the facts to justify this position. Steve Usdin Alexion Pharmaceuticals Inc. AstraZeneca plc Allergan Inc. AbbVie Inc. Celgene Corp. Bristol...
BioCentury | Mar 6, 2021
Management Tracks

Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more

...before its acquisition by Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). He also served as general manager at Celgene Corp....
BioCentury | Feb 20, 2021
Product Development

BMS turns to mechanistic diversity in early oncology pipeline

...has settled on its 2019 acquisition of Celgene Corp....
...added to the BMS pipeline through the Celgene...
...Keytruda pembrolizumab from Merck & Co. Inc. (NYSE:MRK).The Celgene...
BioCentury | Feb 9, 2021
Product Development

Feb. 8 Quick Takes: FDA approves TG’s lymphoma therapy; plus uniQure, Astellas, BMS, Viiv, Avrobio and Veru

...Corp. (NASDAQ:INCY). BMS gained the JAK2 and FLT3 inhibitor through its $74 billion acquisition of Celgene Corp....
BioCentury | Feb 6, 2021
Politics, Policy & Law

Biotech isn’t tech; M&A isn’t all the same

...Atlas Venture, told BioCentury. As a example of the “recycling component of M&A,” Booth cited Celgene Corp.’s...
...2018, which “sent more cash back to investors than all of the IPOs that year.” Celgene...
Items per page:
1 - 10 of 3394